Methods Of Treating Acute Myeloid Leukemia With A Flt3 Mutation


Ontology type: sgo:Patent     


Patent Info

DATE

2016-08-25T00:00

AUTHORS

Amnon Peled , Michal Abraham

ABSTRACT

There is provided a method of treating acute myeloid leukemia (AML). The method includes the step of administering to a patient having AML with a FMS-like tyrosine kinase 3 (FLT3)-mutation a therapeutically effective amount of a CXCR4-antagonistic peptide.

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3142", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "Amnon Peled", 
        "type": "Person"
      }, 
      {
        "name": "Michal Abraham", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-06-0228", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000777930"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2011-10-383406", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004114202"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1586/ehm.11.30", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007495328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.exphem.2010.11.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016542516"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/10428190801895352", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016791109"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2403099", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029950764", 
          "https://doi.org/10.1038/sj.leu.2403099"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2403099", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029950764", 
          "https://doi.org/10.1038/sj.leu.2403099"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.exphem.2011.01.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047028710"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.exphem.2009.12.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048874126"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bcj.2012.5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050505257", 
          "https://doi.org/10.1038/bcj.2012.5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bcj.2012.5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050505257", 
          "https://doi.org/10.1038/bcj.2012.5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.29.15_suppl.tps199", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083951134"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-08-25T00:00", 
    "description": "

There is provided a method of treating acute myeloid leukemia (AML). The method includes the step of administering to a patient having AML with a FMS-like tyrosine kinase 3 (FLT3)-mutation a therapeutically effective amount of a CXCR4-antagonistic peptide.

", "id": "sg:patent.US-20160243187-A1", "keywords": [ "acute myeloid leukemia", "FLT3 mutation", "method", "patient", "tyrosine", "mutation", "peptide" ], "name": "METHODS OF TREATING ACUTE MYELOID LEUKEMIA WITH A FLT3 MUTATION", "sameAs": [ "https://app.dimensions.ai/details/patent/US-20160243187-A1" ], "sdDataset": "patents", "sdDatePublished": "2019-04-18T10:18", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-uberresearch-data-patents-target-20190320-rc/data/sn-export/402f166718b70575fb5d4ffe01f064d1/0000100128-0000352499/json_export_01313.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-20160243187-A1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-20160243187-A1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-20160243187-A1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-20160243187-A1'


 

This table displays all metadata directly associated to this object as RDF triples.

63 TRIPLES      14 PREDICATES      30 URIs      15 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-20160243187-A1 schema:about anzsrc-for:3142
2 schema:author N0a892928e9a148268ac85feeccf1714e
3 schema:citation sg:pub.10.1038/bcj.2012.5
4 sg:pub.10.1038/sj.leu.2403099
5 https://doi.org/10.1016/j.exphem.2009.12.003
6 https://doi.org/10.1016/j.exphem.2010.11.010
7 https://doi.org/10.1016/j.exphem.2011.01.009
8 https://doi.org/10.1080/10428190801895352
9 https://doi.org/10.1158/1535-7163.mct-06-0228
10 https://doi.org/10.1182/blood-2011-10-383406
11 https://doi.org/10.1200/jco.2011.29.15_suppl.tps199
12 https://doi.org/10.1586/ehm.11.30
13 schema:datePublished 2016-08-25T00:00
14 schema:description <p id="p-0001" num="0000">There is provided a method of treating acute myeloid leukemia (AML). The method includes the step of administering to a patient having AML with a FMS-like tyrosine kinase 3 (FLT3)-mutation a therapeutically effective amount of a CXCR4-antagonistic peptide.</p>
15 schema:keywords FLT3 mutation
16 acute myeloid leukemia
17 method
18 mutation
19 patient
20 peptide
21 tyrosine
22 schema:name METHODS OF TREATING ACUTE MYELOID LEUKEMIA WITH A FLT3 MUTATION
23 schema:sameAs https://app.dimensions.ai/details/patent/US-20160243187-A1
24 schema:sdDatePublished 2019-04-18T10:18
25 schema:sdLicense https://scigraph.springernature.com/explorer/license/
26 schema:sdPublisher N2dda96d6f8ae43bbbe36871e821b2491
27 sgo:license sg:explorer/license/
28 sgo:sdDataset patents
29 rdf:type sgo:Patent
30 N00894bdc8c00460cb1edd531be7f2231 rdf:first Nccca025fbbe24fa4ac5ade33d537b700
31 rdf:rest rdf:nil
32 N0a892928e9a148268ac85feeccf1714e rdf:first Nc2d95a83a9d6437e828e0221d3d01660
33 rdf:rest N00894bdc8c00460cb1edd531be7f2231
34 N2dda96d6f8ae43bbbe36871e821b2491 schema:name Springer Nature - SN SciGraph project
35 rdf:type schema:Organization
36 Nc2d95a83a9d6437e828e0221d3d01660 schema:name Amnon Peled
37 rdf:type schema:Person
38 Nccca025fbbe24fa4ac5ade33d537b700 schema:name Michal Abraham
39 rdf:type schema:Person
40 anzsrc-for:3142 schema:inDefinedTermSet anzsrc-for:
41 rdf:type schema:DefinedTerm
42 sg:pub.10.1038/bcj.2012.5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050505257
43 https://doi.org/10.1038/bcj.2012.5
44 rdf:type schema:CreativeWork
45 sg:pub.10.1038/sj.leu.2403099 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029950764
46 https://doi.org/10.1038/sj.leu.2403099
47 rdf:type schema:CreativeWork
48 https://doi.org/10.1016/j.exphem.2009.12.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048874126
49 rdf:type schema:CreativeWork
50 https://doi.org/10.1016/j.exphem.2010.11.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016542516
51 rdf:type schema:CreativeWork
52 https://doi.org/10.1016/j.exphem.2011.01.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047028710
53 rdf:type schema:CreativeWork
54 https://doi.org/10.1080/10428190801895352 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016791109
55 rdf:type schema:CreativeWork
56 https://doi.org/10.1158/1535-7163.mct-06-0228 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000777930
57 rdf:type schema:CreativeWork
58 https://doi.org/10.1182/blood-2011-10-383406 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004114202
59 rdf:type schema:CreativeWork
60 https://doi.org/10.1200/jco.2011.29.15_suppl.tps199 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083951134
61 rdf:type schema:CreativeWork
62 https://doi.org/10.1586/ehm.11.30 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007495328
63 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...